Two-thirds of pharmaceutical manufacturing is outsourced, ISR Reports

Only one-third of manufacturing is currently conducted in-house, from development stages to after commercial launch, according a recent report. The report, published by Industry Standard Research (ISR), explained that the majority of work is outsourced – and mainly to preferred providers, who are netting the largest portion of work. According to Kate Hammeke, Vice President … Continued

Two-thirds of pharmaceutical manufacturing is outsourced; preferred providers pick up largest share

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – November 18, 2016 – A new market research report from Industry Standard Research (ISR), Contract Development and Manufacturing Outsourcing Models, reveals the motivations and strategies behind drug innovators’ decision to outsource and how different outsourcing relationships are selected. The report explores how sponsor … Continued

Best Practices in Study Feasibility

Successfully navigating the medical, clinical, logistical and regulatory challenges associated with establishing the feasibility of a clinical trial is not easy. Insights from sponsor organizations, CROs and sites have been compiled in ISR’s Best Practices in Study Feasibility report. A particular area of interest for readers of the report are the techniques and innovations proffered … Continued

eTMF market to grow sizably over next three years, ISR reports

The adoption of eTMF solutions is accelerating – with more than 50% of investigative sites expected to have access to a sponsor/CRO eTMF application within three years. This figure is according to a recent report published by Industry Standard Research (ISR), which assessed eTMF (electronic trial master file) application access to be around 20% today. … Continued

eTMF Market Expected to Grow Considerably Over the Next Three Years

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – October 27, 2016 – Industry Standard Research (ISR) today announced the release of a report titled “eTMF Market and Service Provider Dynamics.” This report is designed to give eTMF software providers, CROs and pharmaceutical companies information on the current and future landscape of … Continued

Cell Line Selection Predicted to Shift to CMOs, Double Digit Increase in Demand for the Service

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – October 12, 2016 – A new report from Industry Standard Research (ISR), Bioprocessing Services and Technologies Market Trends and Outsourcing Dynamics, offers an in-depth look into the mammalian and microbial expression system manufacturing capabilities currently required by sponsor organizations for biologics in development … Continued

Sponsors and CROs Agree that Integrating Statistical Modeling and Knowledge of Past Performance into Feasibility Analyses Improves Accuracy of Results

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – August 30, 2016 – A new report, Best Practices in Study Feasibility, from Industry Standard Research (ISR) reveals insights into how to successfully navigate many of the challenges—medical, clinical, logistical and regulatory—associated with establishing the feasibility of a clinical trial. A key area … Continued

Specialized Patient Recruitment Firms Bring More Value to a Trial than Adding Sites

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – August 16, 2016 – A new report from Industry Standard Research (ISR), Best Practices in Patient Recruitment, shows that  Sponsors and CROs agree, hiring a specialized patient recruitment firm is a better value than adding more sites to the study. This is, in … Continued

Spend on HEOR Studies Expected to Grow at 9.7% through 2020

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – July 19, 2016 – Industry Standard Research has released a new report, Late Phase Study Trends and Market Outlook (2016-2020), containing findings focused on current dynamics in the Late Phase market and a forecast of how the market will evolve by 2020. “Late … Continued

New ISR Report Reveals Current and Future Dynamics in Phase II/III Market, Changes Expected in Clinical Trial Spend

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – June 21, 2016 – Industry Standard Research has released its comprehensive new report, “Phase II/III Study Trends and Market Outlook (2016-2020),” concerning the trends, resource allocation, and market direction of the pharmaceutical Phase II/III clinical sphere that are expected to take hold in … Continued

One-Third of Cancer Patients Have a Genetic Profile Accessible by Their Oncologist

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – May 24, 2016 – A new market research report titled Personalized Medicine’s Effect on Oncologists’ Treatment Regimens, from Industry Standard Research (ISR), finds that, according to US-based oncologists, currently one-quarter of patients are treated using genetic tumor profiling to inform treatment decisions and … Continued

Two-thirds of Biopharma Sponsors Surveyed Currently Sell or Plan to Sell Biosimilar Products

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – May 17, 2016 – A new report titled Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (3rd edition), from Industry Standard Research (ISR), indicates that the majority of companies with a large molecule offering plan to enter or are already involved in the … Continued

Use Peers’ Experiences To Make Educated CRO Selections

Director of Market Research at Industry Standard Research Rebecca McAvoy discusses with Life Science Leader about how you can use data from other decision-makers to have confidence in your own outsourcing decisions. Having access to performance data from CROs’ users is crucial in making an informed CRO selection. However, it is a lot of information … Continued

The Value Of Experiential Data In Making Informed CMO Selection Decisions

Director of Market Research at Industry Standard Research Kate Hammeke explains why experiential data is more important to CMOs and Sponsors than perception-based data when determining service provider quality. The change from perception-based data to experiential data is important because it shifts the focus of the awards from a CMO’s reputation — a product of … Continued

ISR’s New Report Provides Common Structures, Models for Pharma’s Regulatory Affairs Departments

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – March 29, 2016 – Industry Standard Research (ISR) today announced a new addition to its Department Models and Structures suite of reports.  The new report aims to provide readers with a comprehensive assessment of the organizational environment and landscape of Regulatory Affairs departments … Continued

ISR’s Contract Research Quality Benchmarking Reports Are Now Available

Informing the pharmaceutical drug development, manufacturing and commercialization industry Cary, NC – March 15, 2016 – Industry Standard Research (ISR) today announced the release of its annual CRO Quality Benchmarking series of reports.  These three reports outline in detail the delivery quality of dozens of large, mid-size, and niche CROs for Phase I, Phase II/III … Continued

Clinical Outsourcing Market To See Continued Growth Through 2020

You often hear that this is a good time to be in the pharma industry.  I think that is especially true of the clinical trial sector.  Despite the onslaught of bad press pharma is receiving by both politicians and the general public, advancements in oncology and other serious diseases, coupled with the focus on precision … Continued

Fewer European Prescribers Trust Information Received from Telephone Details than Web-based, In-person Details according to ISR’s New Report

Informing the pharmaceutical drug development, manufacturing and commercialization industry Cary, NC – February 23, 2016 – Industry Standard Research (ISR) today announced the release of their “Electronic Detailing in Europe: Value and Outcomes” report.  With this report, ISR investigates the changing nature of European pharmaceutical companies’ sales detailing.  While the pharmaceutical sales detail remains a … Continued

ISR Projects Continued Growth Propelling the CRO Market Forward

Informing the pharmaceutical drug development, manufacturing and commercialization industry Cary, NC – February 2, 2016 – Industry Standard Research (ISR) today announced a new addition to its Market Analysis suite of reports.  The “2016 Edition of the CRO Market Size Projections: 2015-2020” report provides readers with a comprehensive assessment of the global market for CRO … Continued

When are CMOs used? ISR Reports

While CMOs are currently engaged mainly through tactical outsourcing, this paradigm will shift as more companies begin outsourcing to preferred providers, says ISR report. https://www.outsourcing-pharma.com/Contract-Manufacturing/When-are-CMOs-used-ISR-reports

ISR’s Clinical Outsourcing Department Models and Structures Report Is Now Available

Informing the pharmaceutical drug development, manufacturing and commercialization industry Cary, NC – January 27, 2016 – Industry Standard Research (ISR) today announced a new addition to its Department Models and Structures suite of reports.  The new report aims to provide readers with a comprehensive assessment of the organizational environment and landscape within clinical development outsourcing … Continued

ISR’s Contract Manufacturer Quality Benchmarking Reports Are Now Available

Cary, NC – January 12, 2016 – Industry Standard Research (ISR) today announced the addition of three reports to its Contract Manufacturer Quality Benchmarking suite of reports to provide readers a comprehensive assessment of biopharmaceutical CMO service quality across three key areas of outsourced manufacturing: small molecule, biologic and fill finish. As biopharma companies continue … Continued

2016 CMO Leadership Awards to be announced in Life Science Leader’s March 2016 special supplement

Cary, NC – January 1, 2016 –Life Science Leader (lifescienceleader.com) and Industry Standard Research (ISRreports.com) today announced a publisher-market research partnership, where Industry Standard Research (ISR) will serve as the data collection engine behind Life Science Leader’s annual CMO and CRO Leadership Awards as well as assist in the development of unique data-driven content for the Life … Continued

ISR CUSTOMERS